Merck’s COVID-19 drug reduces hospitalization risk, new study finds
Published: Feb. 21, 2022 at 8:53 AM EST
(CNN) - Merck’s COVID-19 pill appears to be helping people stay out of the hospital.
A new study from India said the drug company’s anti-viral Molnupiravir treatment reduced the risk of hospitalizations by 65%.
Researchers looked at more than 1,200 people with COVID-19 and found that only 1.5% of the group that took the pill had to go to the hospital, compared to 4.3% of those who weren’t treated with the pill.
The study was presented at a major virus and infection conference, but it should be noted that the study has not yet been peer-reviewed.
Copyright 2022 CNN Newsource. All rights reserved.
